United World Antiviral Network aims to study emerging viruses in real-world settings
Official title: United World Antiviral Research Network (UWARN)
Funded at University of Washington · NIH-11613752 · Data updated 2026-11-12
A global network based at the University of Washington is researching how contagious viruses evolve and spread in people and animals, especially in settings with limited resources.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | May 22, 2020 |
| Project end | June 30, 2031 |
| Funding year | 2026 |
| Award (this year) | $131,455 |
| NIH project number | 3U01AI151698-06S4 |
| Project ID | NIH-11613752 on NIH RePORTER |
Who could benefit from this research
✓Could help
Not a traditional patient study; findings could later inform patient care and outbreak response strategies in affected regions.
✕Less likely to help
Direct patient benefits may be limited in the short term to public health insights and policy, rather than individual treatment.
What this research studies
This program connects LMIC partners in Brazil, Senegal, and Taiwan to study viruses that cause illness in humans and animals. It uses a One Health approach to track viral evolution, detect infections, and understand how outbreaks begin and spread across regions. The work includes collaboration with WRAIR labs, expanding to new sites in Thailand, and focuses on high-burden arboviruses like dengue, Zika, chikungunya, and yellow fever, plus other emerging viruses. The network already has a track record of many publications and training across CREID centers, and aims to deepen knowledge of virus evolution, transmission, and environmental drivers. The effort will involve genomic surveillance, field sampling, and analysis to inform prevention and response strategies.
Why it matters
Potential benefit: If successful, this work could improve early detection, understand transmission pathways, and guide safer public health interventions for viral outbreaks in diverse regions.
How similar studies have gone: Previous work has identified SARS-CoV-2 evolution and arboviral dynamics in LMICs, showing the value of global surveillance collaborations.
Where this research is happening
-
University of Washington
Seattle, United States Active
Researchers
- Principal investigator: Rabinowitz, Peter Macgarr — University of Washington
- Study coordinator: Rabinowitz, Peter Macgarr
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.